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performed tn 42 pts in 3 groups; VM undergoing revascularizatJen (R~ 
pts with Ischemic ca.'diomyopathy on increasing medical therapy t~'-~. • 
and dilated eardiomyopathy (DCM). Peak rata.pressure product (RPr: :~ ~s 
derived from hemodynamlca recorded duflng axerclsa and METS were ,, ,aa- 
sured from expired gas analysis. VM was defined by mismatch at pesdren 
emlasion tomagmphy or low-dose a ~ n  at dobutsmlne echo. 
Rasutts, Groups were Comparabio with respect o age and functional status 
before intervention. Change (ch) in RPP and METS at fo,ow-up ~n RVS group 
exceeded that in lhe remainder;, 
. _ Age Pre RPP Ch RPP Pm METS Ch METS 
RVS (n,= 14) 65+9 '19.1.4.1 S.5 ± S.3 4.5-~ 1.0 ' '1"12:1:1.0 
MED (n - t4) 53 ± 6 22.0 =1:6.8 0.2 :E 6.9 4.8 ± 1.2 0.5 • 1.3 
DCM (n = 14) 54±7 2~3 ± 9.~. 0.9±4.8 5.2 :t: 1.9 0.44 * 0.8 
p (RV.S v~)  ...... <o,~! .... o.18 <0.005 0.32 0.0~ 
Extent of VM in the RVS gro~, was 38 ~: 18% of the left ventricle by 
positron emission tomngrsphy and 43 ± 18% by dobutamlno echo. Functional 
improvement in the RVS group nerresponded to an Improvement of ejection 
fracti0n from 26 + 6 to 30 -~ 8%, p < 0.01. 
Conclusions. RVS ~I VM offem a unique opportunity to improve functional 
capacity in pts with left ventdcolar dysfunction. 
5:O0 
~ Cardiac 31P-MR Spe~roscopy  Dur l rg  Dobutamine 
Stress In Older Elite Cycl ists With Left Vsntr icular 
Hypertrophy 
Hildo J. Lamb, Babette M, RuIm, Hugo P. Beyerbacht, Hubert W. Vltegsn, 
Albert de Roos, Ernst E. van der Well. Univers#y Hnsp~taiLe~den, and the 
Interuniverstty Cardiology I~e ,  The Netherlands 
The phasphocreatina (PCr) to adenosinatdphosphate (ATP) ratio (PCr/ATP) 
obtained at rest and dudng dobutamine stress in 12 older elite cyclists with 
left ventdcular hypertrophy (LVH) (mean age 37 years) was Compared to the 
PCr/ATP rath~ acquired in 11 healthy conlrol subjects (mean age 40 years), 
31P-MR spectroscopy was performed at 1.5-T (Gymscan $15) using a 10 
cm diameter surface coil and a 10 minute 3D-ISIS protocol with a dobutamine 
dose of 40/xg/kg/min. Average PCr/ATP values were similar in athletes and 
controls: 1.42 ± 0.16 and 1.34 :t: 0.18 respectively at rest (p ~ 0.27), and 1.22 
:t: 0.15 and 1.16:1:0.17 respectively during stress (p = 0.37) (see figure). 
H~:  C-~C ~ATP ratios at ~ and dtudn8 do1~tamin¢ 
• ~ . . . . . . . . . . . . . . . . .  ~ /~ 
rest stress r~Z 
The observed decrease in PCr/ATP due to dobutamine stress was similar 
in athletes and controls, 0.20 4- 0.20 and 0.18 :E 0.16 respectively (p = 0.80). 
We conclude that the PCrlATP ratio decreases to the same extent in older 
cyclists with LVH and healthy controls due to dobutamlne stress. Accordingly, 
long term athletic training, resulting in LVH, is not associated with changes 
in the cardiac high energy phosphate metabolism. 
5:15 
Ftbflnolytic Activity After Maximal Exercise in Men 
Wlth and Wlthout a History of  Myocardial Infarction 
Be FemhalI, James Mil~nl, Patrick A. Gorn~n, Donald C. Paup. George 
Washington University, Washington, DC 
Exercise ircreasea overall fibrinolytic activity, but its effect in patients with 
a history of myocardial infarction (MI) is not clear. We compared the effect 
of maximal exemise on tissue plasroinngan activator (t-A) and plasminogan 
activator inhibitor-1 (PAl-1) in 13 men with a history of MI and 11 men with no 
history of ML The groups were matched on age (58.2 ~: 7.8 vs 57.6 :E 6.3 yrs) 
and physical activity. All subjects underwent maximal treadmill exercise with 
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, metabolic measurements. MI patients were net asked to discontinue their 
medinations prior to testing~ Blood was co,acted before and immed/ately 
after exercise, t-PA and PAl-1 activity were analyzed using chmmogenic 
substrates with commercially available kits, and were corrected for changes 
in plasma volume. The MI group had signircantly (p < 0.05) lower maximal 
oxygen uptake (27.8 vs 35.9 ml.kg -1.min -t)  And maximal heart rate (140 vs 
157 bpm) compared to ~osa without MI. 
As shown in the tlgure, beth groups significantly Increased t-PA activity (p < 
0.05) and decreased PAl-1 aclivity (p < 0,05) following maxirr~ exercise, but 
there were no differences between groups. Thus, the fibdnolytic responses 
of physically active men with ~ history of MI did not differ from those without 
a history of ML 
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4:00 
Evidence for  Attenuated Heart Rate Control  W'dh 
Beta Blockade in Women With Heart Disease Oudng 
Pregnancy: A Pharmacokinetic and 
Pharmacodynami¢ Study 
Ud E l~am, Agneta Hurst, Awabam Shoton, Kdstina Hoffman-Willey, 
Janet Johnson, Robert Kod~ USC School of MecE, cine, Los Angeles, C. ~. 
Clinical observation suggesting an attenuated response to BB during preg- 
nancy has not ~ valide.ted. We, therefore, compare¢l heart rate {HR) 
~sponse to arenOlOl at rest ane exercise ~ the pP.armacokinetics ~ the 
orug in the 3rd gestational trimester (TT) and 6 wks post partum (PP). 50 mg 
of atenctol q 12 hrs was used in 10 lOtS requiting BB therapy dudng preg- 
nancy. Data cofle¢led included: HR Copra) at rest, H.~ at 6 mtn of treadmill 
exercise (modified Naughfon protcool) just before (t == 0) and 3 hrs after drug 
aomlnistration, ateneiol plasma (APC) and udne concentrations. 
o ~o~ ~ ho=,s 
.............. ~ ~ , ~ - - - - ~ - - - ~  
~e~n~H~ ~e,s 6o~:7 <01os ~*"8 .......... ~e  ~o.os 
Exercise HR 108:E 15 91~11 <0.05 100,6 87~7 <0.05 
~ (ng/n~) 109,47 116:t:79 NS 286:t:105 304±142 NS 
p < o.os,~'n" . . . . . . . . . . . . . . . . . . . . . . . .  
In addition, no difference was found in atenetol clearance (0.10.4- 0.03 vs 
0.12 ± 0.04 1/P.g/hr) And volume of distdbulion (0~75 :f: 0.24 vs 0.71 :I: 0.22 
1/kg) at TT and PP. 
Conclusion: 1) Rasing and exercise HR on atenelof therapy are higher in 
TT than in PP; 2) Augmented HR dudng TT is net related to lower ateneto! 
plasma concentraBons or change in volume of disth1~ition; 3) These findings 
indicate the need for increased doses of BB for heart rate control dudng 
gestation in pts with cardiac disease. 
4:15 
prol=fe.one as Ac, m Oral Lo~ing Therapy in the 
- uonvemon of Recent Onset Altial Fibrillation Is 
Safe and Effective 
A. Capucoi, FACC FESC on behalf of the SATE Group Irwestigators. 
Cardio/o~ Oept,, P/asenz~ 
Aim of this muiticenter andomized study was to evaluate the safety of 
Pmpafenene (PRF, 600 mg acute oral loading dose) in pts with recent onset 
(_ 46 h) Atrial Fibdllatlon (AF) and to observe the effect on the ventdcular 
rate dudng AF of PRFgiven as single drug or associated with digitalis (D). 
246 pts ware enrolled divided into 4 randomized groups: PRF(600 mg); PRF 
p~s D (1 n~2 h); q~ni~ne (Q) (1375 m~12 h) + D; placebo (t~). The 246 
pts (127 males and 119 females; mean age 58.7 :b 10) were comparable 
as clinical findings. 76% of the patients had net any organic heart disease. 
Resu/ts (*p < 0.05): 
Treatment Efficacy % .................... Conversion time (hr) 
3 hours 6 hours 12 hours 24 hours 
PRF 42" 56 66 7'2 4.0~ 4.t* 
PRF + D 5Q* 74* 82" 88' 5.0 -~ 8.6 
Q+D 3Q 64 77 84 5.44-4.5 
PI 27 47 57 77 7.8±7.2 
Atrial flutter > 2:1 was observed in 46 pts: PRF = 12; PRF+ O = 12; Q 
+ D == 9; PI = 13. No one episode of 1:1 col¢luction was recorded by Holier 
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monltodng. Ventdcular ate during persistent AF was not significantly reduced 
with digitalis adjunct and was comparable in the 4 groups (pts lying in bed). 
Condusion: PRFat 600 mg unique oral dose Is safe and of p ro~ efficacy 
in restoring SR in pts with recent onset AR Digitalis does not add any useful 
effect in term of safety and of ventricular ate control in these hospitalized 
pts. PRForal loading dose Is a valide altematwe to the Lv. Infusion in order 
to convert AF te SR. 
4:30 
~ OMerent Pharmacologic Converting Treatment Ior  
Recant-Onset Aldal Rbdl lst ion:  Evaluation on 377 
Pstlents 
Giuseppe Bodani. Alessandro Capu¢cl, Glen Luca Bofto, Ida Rub(no. 
Tizieno Lenzi. Maudzio Onged, Maure Biffi. Paolo Sabbatani. 
Mafio Sartgulneftl, Bruno Magnant. Institute of Cardiovascular Diseases, 
~',ivers~y ofBologna. and Atrial Rbr i l t~  Study Group Italy 
We examined on a patient papuistion of 377 patients (pts.) the efficacy 
and safety of different therapeutic stategies for converting recent-onset atrial 
fibrillation (AF) (_< 7 days duration) to sinus d'~thm (SR). All the pts were 
in NYHA class __. 2, without s~cs or symptoms of heart failure and were 
hcsp'~lised. The pts were randomly allocated to treatment with one of the 
following drugs: Lv.amiodarone (i.v. AM) (5 mg/Kg as bolus, then 1.8 gr/24 
hours) (30 pts), Lv.prol~fenone (i,v, PF') (2 mg/Kg as bolus, then 0.0078 
m~min)  (38 pts), oral loading with prepafenene (oral PF) (600 mg p.o. as 
single dose) (119 pts) and oral loading with flecainido (oral FL) (3Q0 mg p.o. 
as single dose) (69 tots). All the pts were submitted to He(tar moniiodng and 
conversions Io SR were evaluated at 1, 3 and 8 hours. 
Results PLA Lv. AM i.v. PF Oral PF Oral FL 
(11 = 121) (n = 30) In - 38) (n = "119) (n = 69) 
SR < 1 hrs 11 (9%) 2 (7%) 13 (34%) 10 (8%) 9 (13%) 
SR < 3 llrs 22 (18%) 7 (23%) 19 (50%)* 54 (45%)* 39 (56,5%)* 
SR < 8 hrs 45 (37%) 13 {43%) 26 (68%)" 91 (78%)" 52 (75%)* 
Adv. Eft. 0 2 1 4 
*p < 0.01 vs PLA, Adv. Eft. = advePt~e effects 
In conclusion : 1) i.v. AM is not effective at short term in this kind of patient 
population; 2) i.v. PF achieves an higher efficacy within I hour compared to 
oral loading schedules (either with PF or FL) but without different efficacies at 
3 and 8 hours; 3) the overall results undertirm how oral loading with PF or FL 
is a valid alternative to ¢onventi0nals protocols in hospital(sad I~tisnts; 4) the 
evaluation of placebo effect is mandatory for the study of recent-onset AR 
4:45 
~ Competit ive Binding Between Cocaine and 
Udoce ine  
Robert J. Hadman, Dong Liu, Henry S. Loeb, Thomas L, McKiemen, Patdck 
J, Scenlon, Jerry L Bauman. Hines VA Hospital and Loyola University 
Medical Center, Maywcod, IL 
Lidoceine (L), a Na channel Mocker with fast binding kinetics, may compete 
for the same reeapter with cocaine (C), a Na channel Mocker with slew 
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binding kinetics. To see If L can reverse C-induced depression of dVIdtmm 
of phase 0 of the action potential, we studied 16 guinea pig papillary muscle 
preparations timulated at 1 Hz dudng control, dudng exposure to different 
concentrations of C, and dudng exposure of C and a fixed L cormentratlon 
(30 #M), The concentration-inhibition curve (Fig.) shows that addition of L 
shifted ECso of C from 77 uM tO 131.8 #M whereas Ernax remained the same 
(86.1% for C alone and 87.4% for C + L). 
These findings suggest that L Is able to displace C from its binding Sites 
due to L's faster binding kinetics. L may prove to be an antidote of C toxicity 
by reversing C slowing of ventdcular conduction. 
5:00 
~'~5-~ Estrogen Replacement Therapy Normalizes the 
Autonomic Control  o f  the Cardiovascular System In 
Menopausal Women 
Gtusappe M.C. Rosario, Filtppo Leonardo, Piotr Ponlkowsld, Fabio De Luea, 
Peter Collins. National Heart & Lung Institute, London, United Kingdom; 
University Of Rome, and Reggio Calabria Italy 
The menopause is associated with vasomotor instability and signs of in- 
creased sympathetic activity. The aim of the present study was to evaluate 
the effect of estrogen replacement herapy upon the autonomic control of 
the cardiovascular system in 18 menopausal healthy women, The subjects 
undanNent 24 hour ambulatory eleclrecardlographic monitoring before and 
after 1 and 4 months of therapy with estradiol 17/3 (1 mg orally). The au- 
tonomio control of the cardiovascular system was investigated by the study 
of heart rate variability, Mean heart rate was similar at baseline and after 1 
month but was lower at 4 months, A trend toward higher values of heart rate 
variability parameters was obsewed at 1 month but the changes were more 
evident after 4 months of therapy. 
Baseline (n = 18) 1 month (n = 17) 4 months (n - 18) 
mRR (ms) 714 ± 47 725 4. 53 876 4. 27* 
sdRR (ms) 117 4.13 123 =E 12 139 :E 15" 
rMSSD (me) 24.5±3 324.8" 33.14.8" 
pNNS0 (%) 4:1:2 4.64.5 9.8:1:7=" 
HF (ms 2) 92 4. 31 156 4. 49* 225 4. 69** 
LF (ms 2) 325 d: 123*" 465 4. 229* 695 4. 425** 
*p < 0.05, **p < 0.01 conl;~red to baseline 
In conclusion estrogen replacement herapy normalizes the autonomic con- 
trol of the cardiovascular system in healthy menopausal women, The affect of 
estrogen therapy although present after I month of therapy becomes evident 
after 4 months. 
5 :15  
~ Malignant Neurocard iogenic  Syncope: Eff icacy and 
Sa..fety of  ~-Block ing Treatment Guided by Head Up 
. I t  Test 
Gtuseppo Boriani, Mauro Bifli, Peele Sabbatani, Lorenzo Frapatti, 
Gabrtele Bronzer'd, B. MagnanL Institute of Cardiovascular Diseases, 
Univem~ of Bo~n~ Italy 
Thirty patients, mean age 32 ± 13 years (range 11-7~), with recurrent 
syncopat and nsar-syncepal episodes of unexplained origin in the previous 
year (range 2-12, average 6 :E 2) underwent head up tilt test (HUT) lot 
diagnostic purposes. Following 10 minutes rest in recumbent position, HUT 
was performed at at 70 ~ for 25 minutes; if indicated, tsoproterenol testing 
was performed at incremental dosages. All patients expedenced syncope 
dildng HUT (15 during isoproterenol infusion, range 1-3 pg, average 1.6 
.g): 22 were of vesndapressor type, 5 of mixed, and 3 of cardiotnhlbltory 
type, ,8-blocking drugs were prescribed to all patients: 4 pmpranolol (240- 
320 mg in 3 divided doses), 26 metoproicl (100-150 mg twice doily), with 
a dose titration period of 5 to (6 days. HUT was repeated after 1 month: 
28 patients had a negative result, whereas 2 had respectively a persistent 
mixed and ~ vesodepressfve response. In 5 cases a first HUT on ~-blockers 
resulted t :.,e positive but after achievement of full dose HUT test resulted 
At an average follow up of 16 :E 4 months no patient had relapsing syncopal 
episodes; 4 patients (3 with vasodepressor and 1 with mixed type response) 
experienced llghthesdedness. No patient discontinued the drug due to long 
term treatment side effects. 
Clinical Events Previous Year Follow Up 
No. syncopal episodes 6 4. 2 0 p < 0.001 
NO. r~ar-sFcope (moan) 7 4. 0,4 0.3 4. 0.06 p < 0,001 
No. r~ear-syrcope (total) 159 6 p < 0,001 
In conclusion, p-blockers appear to be very effective and well follerated. An 
appropriate titration with of full beta-blockade seem necessary for achieve- 
merit of full efficacy. 
